Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital
- 2 March 2021
- journal article
- letter
- Published by SAGE Publications in Lupus
- Vol. 30 (5) , 856-860
Abstract
No abstract availableFunding Information
- Núcleo de Apoio à Pesquisa “Saúde da Criança e do Adolescente” da USP (to CAS)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/03756-4 to NEA and CAS)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303422/2015-7 to CAS)
This publication has 4 references indexed in Scilit:
- Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19Rheumatology International, 2020
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registryAnnals of the Rheumatic Diseases, 2020
- Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndromeClinics, 2020
- Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemicClinics, 2020